ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,922Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 1526

$1.68M Total Retail Price of All Prescriptions

Rank: 19 out of 1526

772 Patients Receiving at Least One Drug in Part D
68% Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Missouri
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

14% of this provider’s 772 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 772 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 1,022 559 155 S3 1 3
LISINOPRIL 784 512 133 2 1
OMEPRAZOLE 713 425 109 3 5
LEVOTHYROXINE SODIUM 681 439 97 4 2
FUROSEMIDE 573 310 100 5 7
ATORVASTATIN CALCIUM 516 358 76 6 9
SIMVASTATIN 512 376 74 7 4
METFORMIN HCL 505 354 80 8 8
GABAPENTIN 480 278 75 9 13
POTASSIUM CHLORIDE 460 282 78 10 10
AMLODIPINE BESYLATE 423 298 72 11 6
CITALOPRAM HBR 415 257 68 12 17
RANITIDINE HCL 411 189 65 13 18
FLUTICASONE PROPIONATE 381 241 91 14 31
MELOXICAM 359 198 83 15 29
ALPRAZOLAM 344 162 52 B 16 15
PROAIR HFA 340 148 68 17 32
PRAVASTATIN SODIUM 323 211 55 18 19
HYDROCHLOROTHIAZIDE 304 204 54 19 12
CARVEDILOL 289 166 47 20 21
TRAMADOL HCL 277 149 48 21 16
TAMSULOSIN HCL 270 204 47 22 30
WARFARIN SODIUM 263 209 36 23 14
OXYCODONE HCL-ACETAMINOPHEN 251 62 37 S2 24 62
ZOLPIDEM TARTRATE 239 112 41 25 27
METOPROLOL TARTRATE 233 158 36 26 11
SPIRIVA 227 113 39 27 48
ADVAIR DISKUS 223 123 42 28 46
CLOPIDOGREL 219 179 34 29 24
LOSARTAN POTASSIUM 218 120 34 30 22
OXYCODONE HCL 216 91 29 S2 31 75
ATENOLOL 199 141 35 32 25
QUETIAPINE FUMARATE 199 18 22 A 32 58
METOPROLOL SUCCINATE 196 153 38 34 20
CLONAZEPAM 194 74 30 B 35 49
MONTELUKAST SODIUM 183 94 30 36 42
LORAZEPAM 182 125 35 B 37 34
LYRICA 182 88 27 37 82
TRAZODONE HCL 180 90 32 39 33
CYMBALTA 176 55 31 40 41
ALLOPURINOL 161 116 18 41 37
LOVASTATIN 161 99 29 41 23
SYMBICORT 159 74 27 43 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 111 27 44 28
CYCLOBENZAPRINE HCL 155 55 30 R 45 51
CRESTOR 155 98 23 45 38
GEMFIBROZIL 150 67 20 47 102
CELEBREX 141 87 24 48 76
PIOGLITAZONE HCL 140 79 19 R 49 106
NEXIUM 132 77 19 50 35
CARISOPRODOL 127 18 22 R 51 99
OXYCONTIN 123 <11 14 S2 52 98
AMITRIPTYLINE HCL 122 84 20 R 53 57
SERTRALINE HCL 118 63 18 54 26
CLONIDINE HCL 117 73 15 55 70
ISOSORBIDE MONONITRATE ER 115 79 20 56 56
MORPHINE SULFATE ER 113 20 17 S2 57 90
TEMAZEPAM 113 68 23 B 57 117
DIAZEPAM 109 25 21 B 59 74
JANUVIA 107 77 20 60 81
PANTOPRAZOLE SODIUM 106 101* 19 61 36
GLIPIZIDE 103 91 17 62 63
LANTUS SOLOSTAR 100 51 20 63 77
LOSARTAN-HYDROCHLOROTHIAZIDE 99 51 15 64 65
JANUMET 97 <11 <11 65 239
KLOR-CON M20 96 71 27 66 100
DIOVAN 92 69 11 67 66
TERAZOSIN HCL 92 <11 <11 67 136
LEVOFLOXACIN 91 47 71 69 85
VENTOLIN HFA 84 35 33 70 151
COMBIVENT RESPIMAT 83 23 19 71 168
FENTANYL 83 48 17 S2 71 67
POLYETHYLENE GLYCOL 3350 80 27 26 73 59
VENLAFAXINE HCL ER 80 44 11 73 83
NAPROXEN 80 33 19 73 72
LANTUS 79 <11 <11 76 52
ESTRADIOL 78 14 11 R 77 121
DEXILANT 75 37 11 78 175
FENOFIBRATE* 73 <11 <11 79 61
ENALAPRIL MALEATE 72 <11 <11 80 84
DOXAZOSIN MESYLATE 71 66* 13 81 103
METHYLPREDNISOLONE 71 51 63 81 126
ESCITALOPRAM OXALATE 71 37 13 81 55
PREDNISONE 70 37 28 84 45
DIGOXIN 69 64* 11 85 127
HYDROMORPHONE HCL* 69 <11 14 S2 85 190
MIRTAZAPINE 68 50 18 87 50
DOXYCYCLINE HYCLATE 67 29 25 88 156
PAROXETINE HCL 66 43 11 89 68
ZETIA 65 <11 <11 90 86
BUMETANIDE 65 <11 <11 90 163
NOVOLOG FLEXPEN 64 16 14 92 169
ABILIFY 64 <11 12 A 92 115
TIZANIDINE HCL 64 23 17 92 87
DONEPEZIL HCL 62 50 11 95 39
DETROL LA 62 <11 <11 95 148
KLOR-CON 10 62 57* 11 95 123
OXYCODONE-ACETAMINOPHEN 61 33 20 S2 98 78
DILTIAZEM 24HR ER 61 <11 <11 98 128
LUNESTA 61 <11 <11 98 223
PRISTIQ ER 60 <11 <11 101 230
AZITHROMYCIN 59 31 51 102 53
TRIAMCINOLONE ACETONIDE 59 45 34 102 110
SPIRONOLACTONE 58 <11 <11 104 64
DILTIAZEM 24HR CD 57 52* 11 105 107
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 44 30 106 91
BUPROPION XL 56 <11 <11 106 194
DALIRESP 53 <11 <11 108 203
LEVEMIR FLEXPEN 53 <11 <11 108 180
TORSEMIDE 53 <11 <11 108 141
DIGOX 52 <11 <11 111 134
BUSPIRONE HCL 51 <11 <11 112 92
OXYBUTYNIN CHLORIDE 51 <11 <11 112 94
DICYCLOMINE HCL 50 <11 <11 114 185
ONGLYZA 50 <11 <11 114 222
MINOCYCLINE HCL 50 26 40 114 295
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.